Quick Answer
Drugs Made In America Acquisition Corp. reported Common Stock Shares Outstanding of 9.86 million shares for the year ending 2024.
- This data is from Drugs Made In America Acquisition Corp.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2024 to 2024 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: